For: | Cury DB, Cury MS, Elias GVH, Mizsputen SJ. Infliximab to treat severe ulcerative colitis. World J Gastroenterol 2009; 15(14): 1771-1773 [PMID: 19360923 DOI: 10.3748/wjg.15.1771] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i14/1771.htm |
Number | Citing Articles |
1 |
Heidi Waters, Julie Vanderpoel, Scott McKenzie, Orsolya Lunacsek, Meg Franklin, Barbara Lennert, John Goff, Damian H. Augustyn. Stability of infliximab dosing in inflammatory bowel disease: results from a multicenter US chart review. Journal of Medical Economics 2011; 14(4): 397 doi: 10.3111/13696998.2011.583152
|
2 |
Jing Feng, Yueying Chen, Qi Feng, Zhihua Ran, Jun Shen. Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.678424
|
3 |
Ane Søgaard Teisner, Mark A Ainsworth, Jørn Brynskov. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: A Danish single center experience. Scandinavian Journal of Gastroenterology 2010; 45(12): 1457 doi: 10.3109/00365521.2010.510572
|
4 |
Qi Lv, Yao Xing, Yijun Liu, Qingzhu Chen, Jingyi Xu, Lihong Hu, Yinan Zhang. Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidation. Pharmacological Research 2021; 169: 105613 doi: 10.1016/j.phrs.2021.105613
|
5 |
Maryam Fareed Ashoor. Infliximab Induced Leukoencephalopathy and Peripheral Neuropathy: A Case Report and a Review of Literature. Journal of Neurology & Stroke 2018; 8(1) doi: 10.15406/jnsk.2018.08.00274
|
6 |
De-Jun Cui. Early aggressive therapy for severe extensive ulcerative colitis. World Journal of Gastroenterology 2009; 15(33): 4218-4219 doi: 10.3748/wjg.15.4218
Abstract(640) |
Core Tip(487) |
Full Article(HTML)(1366)
|
Full Article (PDF)-507K(200)
|
Times Cited (0)
|
Total Visits (2799)
|
Open
|
7 |
Emily C. L. Wong, Shahin Merat, Cristina Monaco, Parambir S. Dulai, Vipul Jairath, John K. Marshall, Walter Reinisch, Neeraj Narula. Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study. Digestive Diseases and Sciences 2023; 68(6): 2635 doi: 10.1007/s10620-023-07956-8
|